Latest News

In pursuit of next-generation Ebola stockpile vaccines

In pursuit of next-generation Ebola stockpile vaccines

Posted 05/02/2015

Reuters:  As West Africa's devastating Ebola outbreak begins to dwindle, scientists are looking beyond the endgame at the kind of next-generation vaccines needed for a vital stockpile to hit another epidemic hard and fast.

Cautious optimism follows results from trials of early Ebola vaccine

Cautious optimism follows results from trials of early Ebola vaccine

Posted 05/02/2015

The Guardian: The trial conducted at Oxford University paves the way for the vaccine, jointly developed by GlaxoSmithKline (GSK) and the US National Institutes of Health (NIH), to be further tested on patients in west Africa.

Ebola trial suggests vaccine is safe

Ebola trial suggests vaccine is safe

Posted 05/02/2015

BBC: Sixty healthy volunteers were immunised at the University of Oxford's Jenner Institute. The findings, published in the New England Journal of Medicine, show the vaccine generated an immune response against Ebola. But it is not clear whether the vaccine will offer protection against the disease.

Trial finds GSK Ebola shot is safe and provokes immune response

Posted 05/02/2015

Reuters: First results from a human trial of an Ebola vaccine from GlaxoSmithKline show it is safe and generates an immune response, scientists said on Wednesday, but larger trials are needed to see if it protects and if a booster is needed.

First results from Ebola vaccine trial published

First results from Ebola vaccine trial published

Posted 29/01/2015

Press release: The first results from the Ebola vaccine trial carried out by the Jenner Institute found that the vaccine has an acceptable safety profile at the doses tested, and is able to generate an immune response. The paper published in the New England Journal of Medicine reports safety data and immune responses for the volunteers for 28 days after immunisation.

Ebola vaccine trial a success

Posted 05/02/2015

ABC News:An Ebola vaccine has passed initial safety tests at Oxford University, and now thousands of doses are being sent to West Africa for wider trials. The lead researcher, Professor Adrian Hill from Oxford University's Jenner Institute, says more than 10,000 people will now be tested in Liberia, and then more hopefully in Sierra Leone and Guinea.

Vaccines & Infectious Disease Public Engagement Day

Vaccines & Infectious Disease Public Engagement Day

Posted 28/01/2015

Friday 6th March 2015, Oxford University Museum of Natural History The Jenner Institute will be hosting the Opening Event for the Oxfordshire Science Festival, to be held at the University's renowned and beautiful Museum of Natural History. The day will showcase cutting edge research in the ...

1st UK Veterinary Vaccinology Network Conference

1st UK Veterinary Vaccinology Network Conference

Posted 22/12/2014

The conference will focus on four themes: Epidemiology and Economics, Novel Tools and Technologies, Protective Immunity and Immunogen Design. Jenner Investigators will participate as speakers and are represented on the Network's coordinating group.

Oxford ranked first for research

Oxford ranked first for research

Posted 18/12/2014

Press release: Oxford University has been ranked number one in the UK for the quality of its research. The official UK-wide assessment of all university research, the Research Excellence Framework, found that Oxford has the largest volume of world-leading research in the country.

Booster Ebola vaccine enters 1st trials

Booster Ebola vaccine enters 1st trials

Posted 05/12/2014

Press release: The Jenner Institute team led by Professor Adrian Hill have begun testing the safety of a candidate booster vaccine against Ebola, to find out whether it could further increase immune responses. The trial saw 60 people vaccinated between 17 Sep and 18 Nov.

If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.